Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration (Oral, Transmucosal, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); Applic

Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration (Oral, Transmucosal, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); Application (Hospitals & Clinics, Home Care Settings, and Others) and Geography

The global drug delivery systems market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027.

The market is driven by the factors such as, rising incidence of chronic diseases, growing demand for non-invasive drug delivery devices, increasing R&D expenditures in and pharmaceutical and medical device companies. However, the factors restraining the market growth are high cost involved in development of drug delivery devices and product recalls.

With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

The traditional drug delivery techniques, like intramuscular, intravenous, oral and rectal drug administration are not suitable to certain patient populations. The non-invasive methods of drug delivery reduces dosing frequency and simplifies dosing schedules. Moreover, non-invasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing cost may also be less for non-invasive dosage forms as compared to injections in many cases. For instance, inhaled insulin appears to be a non-invasive, well-tolerated and liked modality of treatment of diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human) inhalation powder which was approved by FDA. Thus, due to advantages offered by non-invasive drug delivery devices the drug delivery market is expected to witness growth during the forecast period.

Global drug delivery systems market, based on the route of administration was segmented into oral, transmucosal, injectable, topical, implantable, and ocular. Oral drug delivery system segment led the market for drug delivery systems market in 2018, owing to its ease of administration and increasing demand by the patient population for various therapeutic areas. Based on the distribution channels, the drug delivery systems market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies held the major share owing to the availability of larger range of medications required for the treatment of patient population for various medical conditions. On the basis of application, the market is segmented into hospital & clinics, home care settings, and others. The hospitals and clinics segment held the major share in 2018. This is primarily attributed to the significant number of patient visits to hospitals and the requirement of large volumes of drugs and their respective delivery devices to fulfil to the demand of the large patient population.

Some of the major primary and secondary sources included in the report for the drug delivery systems market are World Health Organization, International Society for Aerosols in Medicine (ISAM), National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Pharmaceutical Research and Manufacturers of America (PhRMA), Inhalation Drug Delivery Association (IDDA), American Lung Association, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.


1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Drug delivery systems market - By
1.3.2 Global Drug delivery systems market - By Application
1.3.3 Global Drug delivery systems market - By Distribution Channel
1.3.4 Global Drug delivery systems market - By Geography
2. GLOBAL DRUG DELIVERY SYSTEMS MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 COVERAGE
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
4. GLOBAL DRUG DELIVERY SYSTEMS- MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 South & Central America - PEST Analysis
5. DRUG DELIVERY SYSTEMS MARKET - KEY MARKET DYANAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Non Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.2 KEY MARKET RESTRAINTS
5.2.1 High Cost Involved In Development Of Drug Delivery Devices
5.2.2 Product Recalls
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Increasing Patient Compliance
5.4 FUTURE TRENDS
5.4.1 Growing New Innovations In Drug Delivery Technology
5.5 IMPACT ANALYSIS
6. DRUG DELIVERY SYSTEMS MARKET - GLOBAL ANALYSIS
6.1 GLOBAL DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE OF PROMINENT PLAYERS
6.3.1 BD
6.3.2 3M
6.3.3 GlaxoSmithKline plc.
6.3.4 Novartis AG
7. DRUG DELIVERY SYSTEMS MARKET - GLOBAL REGULATORY SCENARIO
7.1 NORTH AMERICA
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 EUROPE
7.3 ASIA PACIFIC
7.3.1 Japan
7.3.2 China
7.3.3 India
7.4 MIDDLE EAST & AFRICA
7.4.1 Saudi Arabia
7.4.2 South Africa
7.5 SOUTH & CENTRAL AMERICA
7.5.1 Brazil
8. DRUG DELIVERY SYSTEMS MARKET ANALYSIS AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1 OVERVIEW
8.2 ROUTE OF ADMINISTRATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3 ORAL DRUG DELIVERY MARKET
8.3.1 Overview
8.3.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Solid Oral Drugs Market
8.3.3.1 Overview
8.3.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3.3 SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.4 Liquid Oral Drugs Market
8.3.4.1 Overview
8.3.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.4.3 Liquid Oral Drugs MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.5 Semi-solid Oral Drugs Market
8.3.5.1 Overview
8.3.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.5.3 SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4 TRANSMUCOSAL DRUG DELIVERY MARKET
8.4.1 Overview
8.4.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
SOURCE: THE INSIGHT PARTNERS ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.4.3 Pulmonary Drug Delivery Market
8.4.3.1 Overview
8.4.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.3 PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.4 In-metered Dose Inhalers Market
8.4.3.4.1 Overview
8.4.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.4.3 IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.5 Dry Powder Inhalers Market
8.4.3.5.1 Overview
8.4.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.5.3 DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.6 Nebulizers Market
8.4.3.6.1 Overview
8.4.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.6.3 NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4 Nasal Drug Delivery Market
8.4.4.1 Overview
8.4.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.3 NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.4 Nasal Spray Market
8.4.4.4.1 Overview
8.4.4.4.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.4.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.5 Nasal Drops Market
8.4.4.5.1 Overview
8.4.4.5.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.5.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.6 Nasal Gel Market
8.4.4.6.1 Overview
8.4.4.6.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.6.3 NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.4.5 Buccal Drug Delivery Market
8.4.5.1 Overview
8.4.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.5.3 BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.6 Sublingual Drug Delivery Market
8.4.6.1 Overview
8.4.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.6.3 SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.7 Rectal Transmucosal Drug Delivery Market
8.4.7.1 Overview
8.4.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.7.3 RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.8 Vaginal Transmucosal Drug Delivery Market
8.4.8.1 Overview
8.4.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.8.3 VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5 TOPICAL DRUG DELIVERY MARKET
8.5.1 Overview
8.5.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3 Semi-solid Topical Drug Delivery Formulations Market
8.5.3.1 Overview
8.5.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3.3 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.4 Liquid Topical Drug Delivery Formulations Market
8.5.4.1 Overview
8.5.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.4.3 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.5 Solid Topical Drug Delivery Formulations Market
8.5.5.1 Overview
8.5.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.5.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.6 Transdermal Patches Market
8.5.6.1 Overview
8.5.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
8.5.6.3 TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.7 Transdermal Gels Market
8.5.7.1 Overview
8.5.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
8.5.7.3 TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.8 Others Market
8.5.8.1 Overview
8.5.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8.5.8.3 OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6 INJECTABLE DRUG DELIVERY MARKET
8.6.1 Overview
8.6.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.6.3 Conventional Injection Devices Market
8.6.3.1 Overview
8.6.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.3.3 CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4 Self-Injection Devices Market
8.6.4.1 Overview
8.6.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.3 SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.4 Needle Free Injectors Market
8.6.4.4.1 Overview
8.6.4.4.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.4.3 NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.5 Pen injectors Market
8.6.4.5.1 Overview
8.6.4.5.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.5.3 PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.6 Wearable Injectors Market
8.6.4.6.1 Overview
8.6.4.6.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.6.3 WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7 IMPLANTABLE DRUG DELIVERY MARKET
8.7.1 Overview
8.7.2 Implantable drug delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.7.3 Active Implantable Market
8.7.3.1 Overview
8.7.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.3.3 ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.4 Passive Implantable Market
8.7.4.1 Overview
8.7.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.4.3 Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8 OCULAR DRUG DELIVERY MARKET
8.8.1 Overview
8.8.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.8.3 Eye Drops and Sprays Market
8.8.3.1 Overview
8.8.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
8.8.3.3 Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.4 Gels & Ointments Market
8.8.4.1 Overview
8.8.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
8.8.4.3 Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.5 Ocular Inserts Market
8.8.5.1 Overview
8.8.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
8.8.5.3 Occular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.6 Drug Coated Contact Lens Market
8.8.6.1 Overview
8.8.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
8.8.6.3 Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9. GLOBAL DRUG DELIVERY SYSTEMS MARKET ANALYSIS- BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY DISTRIBUTION CHANNEL 2018 & 2027 (%)
9.3 HOSPITAL PHARMACIES MARKET
9.3.1 Overview
9.3.2 Global Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 RETAIL PHARMACIES MARKET
9.4.1 Overview
9.4.2 Global Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 ONLINE PHARMACIES MARKET
9.5.1 Overview
9.5.2 Global Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. GLOBAL DRUG DELIVERY SYSTEMS MARKET ANALYSIS- BY APPLICATION
10.1 OVERVIEW
10.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATON 2018 & 2027 (%)
10.3 HOMECARE SETTINGS MARKET
10.3.1 Overview
10.3.2 Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 HOSPITALS & CLINICS MARKET
10.4.1 Overview
10.4.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 OTHERS MARKET
10.5.1 Overview
10.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
LIST OF TABLES
TABLE 1. R&D INVESTMENTS BY MAJOR PHARMACEUTICAL COMPANIES
TABLE 2. NORTH AMERICA DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027, BY ROUTE OF ADMINISTRATION (US$ MN)
TABLE 3. NORTH AMERICA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. NORTH AMERICA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. NORTH AMERICA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 6. NORTH AMERICA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 7. NORTH AMERICA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 8. NORTH AMERICA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 9. NORTH AMERICA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 10. NORTH AMERICA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 11. NORTH AMERICA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. NORTH AMERICA DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 13. NORTH AMERICA DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 14. US DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 15. US TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 16. US ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. US PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 18. US INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 19. US SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. US TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 21. US NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 22. US IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 23. US OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 24. US DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 25. US DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 26. CANADA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 27. CANADA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 28. CANADA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 29. CANADA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 30. CANADA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 31. CANADA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. CANADA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 33. CANADA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 34. CANADA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 35. CANADA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 36. CANADA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 37. CANADA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 38. MEXICO DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 39. MEXICO TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 40. MEXICO ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 41. MEXICO PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 42. MEXICO INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 43. MEXICO SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 44. MEXICO TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 45. MEXICO NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 46. MEXICO IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 47. MEXICO OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 48. MEXICO DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 49. MEXICO DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 50. EUROPE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 51. EUROPE TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 52. EUROPE ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 53. EUROPE PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 54. EUROPE INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 55. EUROPE SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 56. EUROPE TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 57. EUROPE NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 58. EUROPE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 59. EUROPE OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 60. EUROPE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 61. EUROPE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 62. GERMANY DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 63. GERMANY TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 64. GERMANY ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 65. GERMANY PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 66. GERMANY INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 67. GERMANY SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 68. GERMANY TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 69. GERMANY NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 70. GERMANY IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 71. GERMANY OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 72. GERMANY DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 73. GERMANY DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 74. FRANCE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 75. FRANCE TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 76. FRANCE ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 77. FRANCE PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 78. FRANCE INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 79. FRANCE SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 80. FRANCE TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 81. FRANCE NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 82. FRANCE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 83. FRANCE OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 84. FRANCE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 85. FRANCE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 86. UK DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 87. UK TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 88. UK ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 89. UK PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 90. UK INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 91. UK SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 92. UK TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 93. UK NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 94. UK IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 95. UK OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 96. UK DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 97. UK DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 98. ASIA PACIFIC DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY ROUTE OF ADMINISTRATION (US$ MN)
TABLE 99. ASIA PACIFIC TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 100. ASIA PACIFIC ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 101. ASIA PACIFIC PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 102. ASIA PACIFIC INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 103. ASIA PACIFIC SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 104. ASIA PACIFIC TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 105. ASIA PACIFIC NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 106. ASIA PACIFIC IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 107. ASIA PACIFIC OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 108. ASIA PACIFIC DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 109. ASIA PACIFIC DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 110. CHINA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 111. CHINA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 112. CHINA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 113. CHINA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 114. CHINA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 115. CHINA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 116. CHINA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 117. CHINA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 118. CHINA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 119. CHINA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 120. CHINA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 121. CHINA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 122. JAPAN DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 123. JAPAN TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 124. JAPAN ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 125. JAPAN PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 126. JAPAN INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 127. JAPAN SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 128. JAPAN TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 129. JAPAN NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 130. JAPAN IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 131. JAPAN OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 132. JAPAN DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 133. JAPAN DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 134. INDIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 135. INDIA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 136. INDIA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 137. INDIA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 138. INDIA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 139. INDIA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 140. INDIA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 141. INDIA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 142. INDIA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 143. INDIA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 144. INDIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 145. INDIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 146. MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 147. MIDDLE EAST & AFRICA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 148. MIDDLE EAST & AFRICA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 149. MIDDLE EAST & AFRICA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 150. MIDDLE EAST & AFRICA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 151. MIDDLE EAST & AFRICA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 152. MIDDLE EAST & AFRICA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 153. MIDDLE EAST & AFRICA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 154. MIDDLE EAST & AFRICA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 155. MIDDLE EAST & AFRICA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 156. MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 157. MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 158. UAE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 159. UAE TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 160. UAE ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 161. UAE PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 162. UAE INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 163. UAE SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 164. UAE TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 165. UAE NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 166. UAE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 167. UAE OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 168. UAE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 169. UAE DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 170. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 171. SAUDI ARABIA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 172. SAUDI ARABIA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 173. SAUDI ARABIA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 174. SAUDI ARABIA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 175. SAUDI ARABIA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 176. SAUDI ARABIA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 177. SAUDI ARABIA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 178. SAUDI ARABIA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 179. SAUDI ARABIA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 180. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 181. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 182. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 183. SOUTH AFRICA TRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 184. SOUTH AFRICA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 185. SOUTH AFRICA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 186. SOUTH AFRICA INJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 187. SOUTH AFRICA SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 188. SOUTH AFRICA TOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 189. SOUTH AFRICA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 190. SOUTH AFRICA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 191. SOUTH AFRICA OCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 192. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 193. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 194. SOUTH AND CENTRAL AMERICADRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 195. SOUTH AND CENTRAL AMERICATRANSMUCOSAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 196. SOUTH AND CENTRAL AMERICA ORAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 197. SOUTH AND CENTRAL AMERICA PULMONARY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 198. SOUTH AND CENTRAL AMERICAINJECTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 199. SOUTH AND CENTRAL AMERICASELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 200. SOUTH AND CENTRAL AMERICATOPICAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 201. SOUTH AND CENTRAL AMERICA NASAL MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 202. SOUTH AND CENTRAL AMERICA IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 203. SOUTH AND CENTRAL AMERICAOCULAR MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 204. SOUTH AND CENTRAL AMERICADRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 205. SOUTH AND CENTRAL AMERICA DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook